J&J's Litigation Bravado In Sharp Relief After Epic Opioid Trial
By Jeff Overley and Emily Field · September 20, 2019, 7:23 PM EDT
Johnson & Johnson's decision this year to risk a $17 billion penalty in the nation's first opioid-crisis trial added one of the most dramatic chapters yet to the company's increasingly remarkable...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login